Cabozantinib: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Cabozantinib. Educational only — not medical advice.
Labeled uses
COMETRIQ is indicated for the treatment of patients with progressive, metastatic medullary thyroid cancer (MTC).
Source: FDA labeling via NIH DailyMed (set 1a0c3bea…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.